TM4SF20 is a polytopic transmembrane protein that functions as a negative regulator of CREB3L1 activation. In resting cells, TM4SF20 inhibits regulated intramembrane proteolysis (RIP) of CREB3L1, blocking the release of this transcription factor from membranes and suppressing collagen synthesis 1. TM4SF20 employs a unique regulatory mechanism called regulated alternative translocation (RAT), where ceramide exposure triggers inversion of the protein's membrane topology 2. This topological reorientation converts TM4SF20 from an RIP inhibitor to an activator, promoting CREB3L1 cleavage and nuclear translocation 3. The RAT mechanism depends critically on specific residues including Asn-26 within a GXXXN motif in the first transmembrane helix, along with Pro-29 and adjacent hydrophobic residues 4. Loss-of-function mutations in TM4SF20, including a complex deletion removing exon 3, associate with specific language impairment 5, presenting with early language delay and cerebral white matter hyperintensities in affected individuals 5. These findings suggest TM4SF20 dysfunction impairs CREB3L1-mediated collagen and extracellular matrix regulation, with neurological consequences during early development.